Form 4 for YARW Yarrow Bioscience, Inc.
Accepted 2026-07-24 17:00:05 ET · period of report 2026-07-23 · accession 0001727794-26-000010 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-07-24 17:00 | 2026-07-23 | YARW | Domzalski David | Pres AND CEO, Dir | F - Tax | $0.8976 | -79.4K | 347.2K | -19% | -$71.3K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-07-23 | F | D | 79,391 | $0.8976 | 347,174 | D | — | — | (F1) Represents shares that have been withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted stock units. |